JP Morgan Maintains Underweight on QuidelOrtho, Raises Price Target to $12

Benzinga Newsdesk www.benzinga.com Positive 80.6%

Neg 0% Neu 0% Pos 80.6%

JP Morgan analyst Casey Woodring maintains QuidelOrtho (NASDAQ:QDEL) with a Underweight and raises the price target from $11 to $12.